GSK_ Annual_Report_2021-22

GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 46 Annexure ‘B’ to the Directors’ Report Business Responsibility (BR) Report Section A: General information about the Company 1. Corporate Identity Number (CIN) : L24239MH1924PLC001151 2. Name of the Company : GlaxoSmithKline Pharmaceuticals Limited 3. Registered Address : GSK House, Dr. Annie Besant Road, Worli, Mumbai - 400030 4. Website : https://india-pharma.gsk.com/en-in/ 5. Email ID : in.investorquery@gsk.com 6. Financial year reported : 1 April 2021 to 31 March 2022 7. Sector(s) that the Company is engaged in (industrial activity code-wise): Group Class Sub class Description 210 2100 21001 Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure sugar 8. List three key product/services that the Company manufactures/provides (as in balance sheet): : Betamethasone, Potassium Clavulanate with Amoxycillin and Pneumococcal Polysaccharide and Conjugate Vaccine (adsorbed) Ph. Eur. 9. Total number of locations where business activity is undertaken by the Company: a. Number of international locations : Nil b. Number of national locations : One manufacturing plant at Nashik, head office in Mumbai and seven branches in India. 10. Markets served by the Company : Across all markets in India Section B: Financial details of the Company 1. Paid-up capital ( ` in lakhs) : 169,40.60 2. Total turnover of continuing operations ( ` in lakhs) : 3217,50.87 3. Total profit after taxes of continuing operations ( ` in lakhs) : 376,57.54 4. Total spending on Corporate Social Responsibility (CSR) as percentage of profit after tax (%) : The Company’s total spending on CSR is 2% of the average net profit in the previous three financial years. 5. List of activities in which expenditure in 4 above has been incurred : Please refer to Annexure ‘A’ to Directors’ Report for the details. Section C: Other details 1. Does the Company have any subsidiary Company/Companies? Yes, the Company has one subsidiary - Biddle Sawyer Limited. 2. Do the subsidiary Company/Companies participate in the BR initiatives of the parent Company? If yes, then indicate the number of such subsidiary Company(s)? Business responsibility initiatives of the parent Company are applicable to all subsidiary Company(s). 3. Do any other entity/entities (e.g. suppliers, distributors, etc.) that the Company does business with, participate in the BR initiatives of the Company? If yes, then indicate the percentage of such entity/entities? [less than 30%, 30-60%, more than 60%] The GSK Code is applicable to all the business entities which do business with the Company. The business associates do not directly participate in business responsibility initiatives of the Company.